Convergence Pharmaceuticals launches with £22.4 million

A new UK pharmaceutical company, Convergence Pharmaceuticals Ltd, has raised £22.4 million in a Series A round in connection with its launch as spin-out of GlaxoSmithKline Plc. The company has a portfolio of analgesic medicines.